• English
  • Français
  • Español
  • Facebook
  • RSS
  • Twitter

Therapeutics Initiative

Independent Healthcare Evidence

  • TI
  • About Us
    • Oversight Committee
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
    • Questions & Answers
  • Therapeutics Letter
  • Our Evidence Reviews
  • Portrait
  • Continuing Education
  • Contact Us
  • Subscribe
Home > News > Therapeutics Letter #90: Reducing polypharmacy: A logical approach

Therapeutics Letter #90: Reducing polypharmacy: A logical approach

September 2, 2014 News Leave a Comment

Share

Listen to the TI podcast on this topic here…

In the latest Therapeutics Letter (#90 – Jun-Jul 2014), UBC’s Therapeutics Initiative urges physicians to take every opportunity to prune the number of drugs their patients are taking, so as to minimize harmful reactions and save money for both the patient and society. The TI is urging physicians to adopt a “common sense” and “Golden Rule” approach when prescribing drugs, to minimize “polypharmacy” — the use of multiple drugs simultaneously.

“Rational prescribing requires restraint and wisdom in initiating chronic drug therapy, but also fundamental change in our philosophy of medicinal care,” says the Therapeutics Letter, which is sent to prescribing physicians and pharmacists throughout British Columbia.

The TI notes that B.C. has the lowest average per capita drug costs in Canada, due mostly to lower consumption of multiple drug classes.
“However, there is ample room to improve,” the letter states.

The TI calls on physicians to routinely challenge complex medication regimes, and to lean towards simplification when it can improve patients’ health. It then provides seven steps that doctors, pharmacists, nurses, patients and their families can use to help in “deprescribing”.

Read Therapeutics Letter #90 here…

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

 

  • About Us
    • Oversight Committee
    • Questions & Answers
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
  • Portrait
    • Frequently Asked Questions
    • Portrait Contact
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
    • Best Evidence
  • Contact Us
  • Terms & Policies
    • Legal Information & Terms of Use
    • Privacy Policy
    • Acceptable Use Policy

Categories

  • News (123)
  • Therapeutics Letter (133)
  • Portrait (1)
  • Drug Assessments (39)
  • PharmacoEpidemiology (75)
  • Podcasts & Videos (50)

Recent Seminars

Dr. Jessica Otte: We Need To Talk About Tramadol

Share

[Feb 10] Therapeutics Initiative Best Evidence Webinar: Sex and Post-SSRI Evidence-based Medicine Dysfunction

Register
Share

[Mar 10] Therapeutics Initiative Virtual Workshop – Using Evidence in Shared Decision Making: A Case-based, Critical Appraisal Approach for Busy Clinicians

Register
Share

Therapeutics Initiative

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. Read more Donate

Contact

2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3
Contact us
Office: +1 604-822-0700
Fax: +1 604-822-0701

UBC logoISDB logo

Subscribe

Subscribe to receive email notifications from the TI about the Therapeutics Letter, upcoming educational events, personal prescribing portraits and other news and recent publications. SUBSCRIBE

© 1994 - 2021 Therapeutics Initiative · Terms & Policies · TM